đź“Ł ADDS 2027 Save the Date!

We hope you'll consider joining us for our 5th meeting, ADDS 2027, taking place Feb 8-10, 2027 at the Georgian Terrace Hotel in Atlanta, GA.

NOTE: Our office will be closed Friday, June 19th in observance of Juneteenth. We will reopen at regular business hours on Monday, June 22nd.

Subscribe to Receive Updates

Precision at Every Phase™

gfx1-2

Our Vision

Shaping Clinical Research Through Purposeful Digital Innovation

At Ametris, we envision a world where every phase of clinical research is empowered by thoughtful, precise digital innovation.

As trials evolve, so must the tools and insights that guide them. We believe that truly impactful research isn’t just about collecting data; it’s about making that data meaningful, actionable, and accessible across the entire trial journey. Through connected, end-to-end digital solutions, Ametris helps shape a future where scientific discovery is faster, more inclusive, and more aligned with patient realities—advancing not just research, but global health outcomes.  

Our Mission

Pioneering the Digital Transformation of Clinical Research

At Ametris, we partner with life sciences organizations to transform complex, real-world patient data into evidence that drives progress. Our end-to-end platform integrates advanced wearable technology, expert scientific consultation, and regulatory-aligned analytics to support every phase of a clinical trial. From initial study design through submission, we simplify digital implementation and ensure that data serves its highest purpose: informing better science and improving lives.

icn4

Collaborative Team

Our strength lies in our unity. We show up for each other authentically and always act with empathy, respect, and purpose.

icn5

Passionate

We care deeply about our work and have an uncompromising focus on it. We take full ownership of our part in shaping science.

icn1

Trustworthy

Our integrity builds lasting trust—with each other, our clients, and the communities we serve.  We seek to work with others who share these values of honesty and transparency.

icn3

Innovative

We lead with innovation—in our technology, our thinking, and the way we support every phase of a trial. At Ametris, we’re always striving to learn, grow, and improve.

icn2

Data Obsessed and Science Based

Scientific rigor is our standard. Robust and meaningful data isn’t just what we deliver; it’s what drives every insight and decision we make.

AMETRIS Initiatives

Empowering the Future of Healthcare

Elevating Our Impact

Elevating Our Impact

We support local nonprofits and causes that promote public health and education, especially in underserved populations, because equitable access is foundational to progress.
Taking It to the Next Level

Taking It to the Next Level

The Ametris Digital Endpoint Accelerator Research (DEAR) Grant was established to close critical evidence gaps and advance the adoption of digital endpoints in less healthy, clinically underserved populations.
Advancing Meaningful Research

Advancing Meaningful Research

Through Digital Endpoint Collaboration
to accelerate Outcome DEvelopment (DECODE), Ametris engages in pre-competitive collaboration with pharmaceutical leaders to develop digital outcome measures for dermatology and obesity drug development programs.

Join the Team!

View Openings
Our Story

Our Story

More Than Metrics

Founded in 2004, Ametris (formerly ActiGraph) began with a mission to deliver scientifically rigorous, device-based data for clinical research. Known for pioneering actigraphy wearables, we helped set the standard for real-world, continuous monitoring across academic and pharmaceutical studies.

Over the past two decades, we've grown into a global digital health solutions provider offering an integrated, end-to-end platform that spans data collection, AI-powered analytics, regulatory engagement, and operational support. From designing endpoints to submitting evidence, Ametris delivers validated insights that help researchers run smarter trials and make stronger decisions.

But what truly sets us apart isn't just our technology; it's our people. We work alongside research teams to navigate complexity, reduce patient burden, and generate the insights needed to accelerate promising therapies.

In 2026, we joined Signant Health, uniting our validated, wearable-derived digital outcome measures with industry-leading eCOA solutions. Together, we give sponsors a single partner for integrated evidence generation, combining patient-reported outcomes with continuous sensor data.

At Ametris, we're not just supporting studies. We're shaping the future of evidence generation—turning continuous data into continuous progress.

From First Step to Final Submission

Why Ametris Is the End-to-End Digital Health Partner of Choice

Applied Research Excellence

Since 2004, Ametris has been recognized as a pioneer in motion-sensing wearable technology and real-world monitoring, earning our place at the forefront of modern clinical trials. For more than 20 years, we have supported the translation of data into insights that help us better understand and promote human health.

Operational Support Excellence

From training to logistics to reporting, Ametris handles every aspect of study execution, ensuring seamless delivery across even the most complex trials. To date, our digital health technology solutions have been deployed in more than 260 clinical drug trials, and they continue to pave the way for real-world, remote data capture in this complex and highly regulated space.

End-to-End Customer Support

Ametris’s integrated approach to clinical trials connects high-quality digital data and clinical benefits. Our market-leading digital health technology solutions provide flexible data capture and transfer configurations to support various study designs and methodologies, including a device-inclusive platform and decentralized trial capabilities.

World-Class Science Team

Ametris has built a world-class internal team of scientists that can support a study team throughout the trial lifecycle with services ranging from endpoint design and algorithm validation to biostatistical analysis and regulatory engagement.

Future-Proof Data and Transparency

Ametris delivers future-proof data that remains valuable as new algorithms and analytic methods emerge. We prioritize transparency by leveraging publicly available, community-developed algorithms, ensuring long-term trust, flexibility, and scientific rigor.

Recognized Industry Experts

Appearing 30,000+ peer-reviewed scientific publications, used in 285+ clinical trials, and available in 150+ countries, Ametris is the world’s most established end-to-end digital health partner. Our widespread adoption has driven extensive validation and key industry partnerships, providing access to algorithms that deliver meaningful health outcome measures from high-precision digital data.

Let’s Connect

Have questions or need assistance? Our team is here to help. Learn more about how Ametris' innovative solutions can support your research and patient care goals.

Get In Touch